Targeting RNA Polymerase I Transcription Synergises With TOP1 Inhibition in Potentiating the DNA Damage Response in High-Grade Serous Ovarian Cancer

doi 10.1101/849307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Targeting IDH1 as a Pro-Senescent Therapy in High-Grade Serous Ovarian Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

Small RNAs and the Competing Endogenous RNA Network in High Grade Serous Ovarian Cancer Tumor Spread

Oncotarget
Oncology
2016English

PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer

Oncotarget
Oncology
2018English

Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma

Journal of Oncology
Oncology
2010English

Correction: Enhanced GAB2 Expression Is Associated With Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy